Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes

International Journal of Obesity

Volumn 22, Issue 2, 1998, Pages 157-163

  Rosenkranz, K ^a   Hinney, A ^a   Ziegler, A ^a   Von Prittwitz, S ^a   Barth, N ^a   Roth, H ^a   Mayer, H ^e   Siegfried, W ^f   Lehmkuhl, G ^b   Poustka, F ^c   Schmidt, M ^d   Schafer H ^a   Remschmidt, H ^a   Hebebrand, J ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Children's Hospital Hochried   (Germany)

^f Obesity Treatment Center Insula   (Germany)

Author keywords

Anorexia nervosa; NPY Y1 receptor; NPY Y5 receptor; Obesity; Temperature gradient gel electrophoresis; Underweight

Indexed keywords

NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANOREXIA NERVOSA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXON; FEMALE; FOOD INTAKE; GEL ELECTROPHORESIS; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; REGULATORY MECHANISM; SCHOOL CHILD; SCREENING;

EID: 14444280915     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800550     Document Type: Article

References (36)

1. Munglani R, Hudspith MJ, Hunt SP. The therapeutic potential of neuropeptide Y. Drugs 1996; 52: 371-389.
2. Akabayashi A, Levin N, Paez X, Alexander JT, Leibowitz SF. Hypothalamic neuropeptide Y and its gene expression: Relation to light/dark cycle and cirulating corticosterone. Mol Cell Neurosci 1994; 5: 210-218.
3. Herzog H, Baumgartner M, Vivero C, Selbie LA, Auer B, Shine J. Genomic organisation, localization, and allelic differences in the gene for the human neuropeptide Y Y1 receptor. J Biol Chem 1993; 268: 6703-6707.
4. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R: Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 1995; 270: 22661-22664.
5. Herzog H, Hort YJ, Shine J, Selbie LA. Molecular cloning, characterization, and localization of the human homolog to the reported bovine NPYY3 receptor: Lack of NPY binding and activation. DNA Cell Biol 1993; 12: 465-471.
6. Bard JA, Walker MW, Branchek TA, Weinshank RL. Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 1995; 270: 26762-26765.
7. Gerald C, Walker AW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 1996; 382: 168-171.
8. Hu Y, Bloomquist BT, Cornfield LJ, DeCarr LB, Flores-Riveros JR, Friedman L, Jiang P, Lewis-Higgins L, Sadlowski Y, Schaefer J, Velazquez N, McCaleb ML. Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J Biol Chem 1996; 271: 26315-26319.
9. Matsumoto M, Nomura T, Momose K, Ikeda Y, Kondou Y, Akiho H, Togami J, Kimura Y, Okada M, Yamaguchi T. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 1996; 271: 27217-27220.
10. Rose PM, Lynch JS, Frazier ST, Fisher SM, Chung W, Battaglino P, Fathi Z, Leibel R, Fernandes P. Molecular genetic analysis of a human neuropeptide Y receptor - The human homolog of the murine 'Y5' receptor may be a pseudogene. J Biol Chem 1997; 272: 3622-3627.
11. Stanley BG and Leibowitz SF. Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 1984; 35: 2635-2642.
12. Grundemar L and Håkanson R. Neuropeptide Y effector systems: Perspectives for drug development. Trends Pharmacol Sci 1994; 15: 153-159.
13. Kaye WH, Berrettini W, Gwirtsman H, George DT. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry 1990; 47: 548-556.
14. Chua SC, Brown AW, Kim K, Hennessey KL, Leibel RL, Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression: Effects of strain background and the diabetes mutation. Mol Brain Res 1991; 11: 291-299.
15. Wilding JPH, Gilbey SG, Bailey CJ, Batt RAL, Williams G, Ghatei MA, Bloom SR. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of obese (ob/ob) mouse. Endocrinology 1993; 132: 1939-1944.
16. Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381: 415-418.
17. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science 1996; 274: 1704-1707.
18. Tomaszuk A, Simpson C, Williams G. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm Res 1996; 46: 53-58.
19. Herzog H, Darby K, Ball H, Hort Y, Beck-Sickinger A, Shine J. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests co-ordinate transcriptional regulation. Genomics 1997; 41: 315-319.
20. Herzog H, Selbie LA, Zee RYL, Morris BJ, Shine J. Neuropeptide-Y Y1 receptor gene polymorphism: Cross-sectional analyses in essential hypertension and obesity. Biochem Biophys Res Commun 1993; 196: 902-906.
21. Côté G, Tremblay A, Dionne FT, Bouchard C. DNA sequence variation at the NPY and NPY Y1 receptor loci and human food intake. Obes Res 1995; 3 (suppl 3): 354s, Abstract.
22. Riesner D, Henco K, Steger G. TGGE: A method for the analysis of conformational transitions and mutations in nucleic acids and protein. In: Crambach A, Dunn MJ, Radola BJ (eds): Advances in Electrophorexis. VCH Press: Weinheim, 1991, vol 4, pp 169-250.
23. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nature Genet 1993; 5: 111-117.
24. Hinney A, Luckenbach C, Ritter H. Temperature gradient gel electrophoresis: Rapid detection of alpha-1-antitrypsin deficiency carriers. Electrophoresis 1992; 13: 279-282.
25. Sheffield VC, Cox DR, Lerman LS, Myers RM. Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of a single-base changes. Proc Natl Acad Sci 1989; 86: 232-236.
26. 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa. Int J Obes 1997; 21: 224-230.
27. Lentes K-U, Hinney A, Ziegler A, Rosenkranz K, Wurmser H, Barth N, Jacob K, Coners H, Mayer H, Grzeschik K-H, Schäfer H, Remschmidt H, Pirke KM, Hebebrand J. Evaluation of a Cys23Ser mutation within the human 5-HT2C receptor gene: No evidence for association of the mutant allele with obesity or underweight in children, adolescents and young adults. Life Sci 1997; 61: 9-16.
28. Hebebrand J, Himmelmann GW, Heseker H, Schäfer H, Remschmidt H. Use of percentiles for the body mass index in anorexia nervosa: Diagnostic, epidemiological and therapeutic considerations. Int J Eating Disorder 1996; 19: 359-369.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. (4th edn) American Psychiatric Association: Washington, 1994.
30. WHO: Composite International Diagnostic Interview (CIDI). (a) CIDI Interview version 1.0, (b) CIDI-user manual, (c) CIDI-training manual, (d) CIDI computer programs. WHO: Geneva, 1990.
31. Nurnberger J Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T. Diagnostic interview for genetic studies. Rationale, unique features and training. NIMH Genetics Initiative Arch Gen Psychiatry 1994; 51: 849-859.
32. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.
33. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
34. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by PCR followed by high-resolution PAGE. AM J Hum Genet 1991; 48: 137-144.
35. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci 1993; 90: 2842-2845.
36. Roche C, Boutin P, Dina C, Gyapay G, Basdevant A, Hager J, Guy-Grand B, Clément K, Froguel P. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity. Diabet 1997; 40: 671-675.